Navigation Links
IDEXX Laboratories Announces Fourth Quarter and Full Year Results
Date:1/30/2009

costs is not representative of ongoing operations and is not indicative of future performance. Specific acquisition-related discrete costs do not include amortization expense related to acquired intangible assets. We applied the statutory income tax rates of the applicable tax jurisdictions to calculate the after-tax impact of these discrete items. (2) We believe that the impact of the disposition of certain pharmaceutical product lines and the related restructuring of the remaining pharmaceutical business in the fourth quarter is not indicative of future performance because significant transactions and related costs of a similar nature are not likely to recur within a reasonable period. In the fourth quarter of 2008 we completed a transaction to sell our ACAREXX and SURPASS pharmaceutical products and a product currently under development, which were a part of our CAG segment, and subsequently restructured the remaining pharmaceutical business. (3) The sum of the individual items may not equal the non-GAAP measurement due to rounding of the individual items in this presentation.

    IDEXX Laboratories, Inc. and Subsidiaries
    Non-GAAP Financial Measures
    Amounts in thousands except per share data (Unaudited)

                                               Twelve Months Ended
                                                             Income from
                                        Gross Profit         Operations
                                     Dec. 31,   Dec. 31,  Dec. 31,   Dec. 31,
                                       2008     2007       2008      2007

    GAAP measurement                $529,766  $463,522  $172,456  $136,183
       % of revenue                    51.7%     50.2%     16.8%     14.8%
    Write-downs of certain
     pharmaceutical assets (1)             -    10,138         -    10,138
    Ac
'/>"/>
SOURCE IDEXX Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related medicine news :

1. IDEXX Laboratories to Release 2008 Fourth Quarter and Full-Year Financial Results
2. IDEXX Laboratories Names William Brown Corporate Vice President
3. IDEXX Laboratories to Present at William Blair 28th Annual Growth Stock Conference
4. IDEXX Laboratories to Release 2008 First Quarter Financial Results
5. IDEXX Laboratories Announces Increase in Share Repurchase Program
6. IDEXX Laboratories Announces Fourth Quarter Results
7. IDEXX Laboratories to Release 2007 Fourth Quarter and Full-Year Financial Results
8. IDEXX Laboratories to Present at JPMorgan Healthcare Conference
9. Caraco Pharmaceutical Laboratories, Ltd. Reports Results for the Third Quarter and First Nine Months of Fiscal 2009
10. Bedford Laboratories(TM) to Begin Shipping Irinotecan HCl Injection
11. Metametrix Announces Acquisition of Accu-Chem Laboratories
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/1/2014)... Spain Monday 1 September 2014: Permanent atrial fibrillation ... AF, according to research in more than 6 000 ... Vanassche from Belgium. The findings suggest that a simple ... doctors to better estimate stroke risk. , Ischaemic stroke ... accounting for over a million deaths and many more ...
(Date:9/1/2014)... BCC Research ( http://www.bccresearch.com ) reveals in ... GLOBAL MARKETS , the global market for blood-brain barrier ... expected to reach $38.7 million in 2014. This is ... which is equivalent to 64.9% compound annual growth rate ... segment is forecasted to grow at a CAGR of ...
(Date:9/1/2014)... involved in federally-filed Tylenol lawsuits ( http://www.tylenollawsuitclaims.com/ ) are ... where issues related to claims involving the pain reliever ... Bernstein Liebhard LLP reports. , According to a ... the meeting is scheduled to take place on September ... of several Tylenol conferences that have taken place this ...
(Date:9/1/2014)... September 01, 2014 Ontraport , ... marketers that was developed to automate the small intricacies ... attention of Shane Michaels, prompting an investigative review. ... daily duty of managing all of the small details ... quite overwhelming,” reports Michaels. “That’s why Ontraport has become ...
(Date:9/1/2014)... 01, 2014 AttorneyOne.com, a recognized authority ... latest information from the FDA on DePuy Synthes ... announced on August 28, that specific lots of DePuy ... I) as the device may reverse directions after surgery. ... (CMF) Distraction System is an implant used to lengthen ...
Breaking Medicine News(10 mins):Health News:Permanent AF doubles risk of stroke compared to paroxysmal AF 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 2Health News:Global Market for Blood-Brain Barrier (BBB) Technology to Reach $471.5 Million in 2019; Highest CAGR Growth in Latin American Market With 10.5% 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 2Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 3Health News:Tylenol Lawsuit News: Bernstein Liebhard LLP Notes Upcoming Status Conference in Pennsylvania Litigation 4Health News:Ontraport: Review Exposes Automated Platform for Online Marketing Management 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 2Health News:DePuy Synthes Craniomaxillofacial Distraction System Recalled (Class I): AttorneyOne Monitors and Keeps Consumers Informed 3
... be responsible for triggering food allergy in humans and would ... ,Researchers led by M. Cecilia Berin at Mount Sinai ... that CD23, a protein normally present in a person's intestinal ... with allergic reactions. ,The researchers studied nine paediatric ...
... in a number of issues which is corrupting the system, ... dwindling// numbers of health workers, has left very little to ... Medical Association president Dr Mukesh aikerwal said "There is a ... and save in order to fund a $200,000-plus medical degree. ...
... are being driven into a state of mental health crisis ... a report released by the Mental Health Commission.// ... people would be taken to acute inpatient services in a ... Hilary Lapsley and Heather Barnett based on interviews with 40 ...
... increasingly unchecked spread of the HIV/AIDS epidemic could affect ... years according to a report on the Macroeconomic// and ... conducted by the National Council of Applied Economic Research ... Programme (UNDP) and National AIDS Control Organisation (NACO). ...
... decision of the BSF to terminate the services of a ... on account of contracting the dreaded HIV ailment. // ... upheld on the ground that the victim was disabled due ... ,A Division Bench of Justice Mukul Mudgal and Justice ...
... users in US and South Africa practice unsafe sex with ... ,"Forty percent of the HIV-positive women in our sample were ... of the time, condoms were not used consistently," said lead ... the June issue of the Journal of Acquired Immune Deficiency ...
Cached Medicine News:Health News:Protein Behind Food Allergies Identified 2Health News:More Effective Mental Health Services Required 2Health News:HIV/AIDS Epidemic to Cause Adverse Effects to Indian Economy 2
(Date:8/29/2014)... , Aug. 29, 2014 The Competitive ... regulatory and marketplace changes. CI leaders who adjust will ... In a new Best Practices, LLC study CI ... actionable insights, including: - Use secondary research ... primary research - Internal staff who are ...
(Date:8/29/2014)... , Aug. 29, 2014 Medina Medical announced ... and member of the Board of Directors on August ... device development and commercialization experience, including over a decade ... previously served as a Partner of the medical device ... CEO of two Foundry start-ups. Mr. Engelson previously served ...
(Date:8/29/2014)... Aug. 29, 2014 Research and Markets  has ... Pipeline Insight 2014" report to their offering. ... is one of the largest segments of pharmaceuticals industry. The ... while the available therapies were unable to meet the market ... market for CNS disorder, especially over the past two decades. ...
Breaking Medicine Technology:Using the Competitive Intelligence Function to Drive Better Business Decisions in the Pharmaceutical Sector 2Medina Medical Announces Erik T. Engelson Joins as Chief Executive Officer 2US CNS Disorders Drug Pipeline Insight 2014 2
... , ROCKVILLE, Md., Dec. 9 Novavax, ... 25, 2009, it closed its previously announced public offering of ... Novavax received net proceeds from the sale of the ... approximately $21 million, which will be used for preclinical studies ...
... , GAITHERSBURG, Md, Dec. 9 Lentigen Corporation, ... of lentiviral gene delivery technologies, announced today that it ... business innovation research (SBIR) grant for a program on ... using Lentivirus". In this program, Lentigen will collaborate ...
Cached Medicine Technology:NOVAVAX Announces Closing of Public Offering of 6,800,000 Shares of Common Stock 2Lentigen Awarded Phase I SBIR Grant for Hepatitis C Vaccine 2
... Centuries of German Craftsmanship ... instrumentation in the world. Ocutek ... you! Only holders of the ... and eight-year apprenticeship, are qualified ...
... German Craftsmanship have produced the ... world. Ocutek now makes them ... of the coveted Meisterbrief certificate, ... are qualified to become Ocutek ...
... of German Craftsmanship have produced ... the world. Ocutek now makes ... holders of the coveted Meisterbrief ... apprenticeship, are qualified to become ...
... Centuries of German Craftsmanship have ... in the world. Ocutek now ... Only holders of the coveted ... eight-year apprenticeship, are qualified to ...
Medicine Products: